Recent News

• 08.08.2025 - Repare Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results
• 08.08.2025 - Repare Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results
• 07.15.2025 - Repare Therapeutics Enters Exclusive Worldwide Licensing Agreement with Debiopharm for Lunresertib
• 07.15.2025 - Repare Therapeutics Enters Exclusive Worldwide Licensing Agreement with Debiopharm for Lunresertib
• 05.13.2025 - Repare Therapeutics Provides Business and Clinical Update and Reports First Quarter 2025 Financial Results
• 05.13.2025 - Repare Therapeutics Provides Business and Clinical Update and Reports First Quarter 2025 Financial Results
• 05.01.2025 - Repare Therapeutics Announces Out-Licensing of its Discovery Platforms to DCx Biotherapeutics
• 05.01.2025 - Repare Therapeutics Announces Out-Licensing of its Discovery Platforms to DCx Biotherapeutics

Recent Filings

• 07.16.2025 - EX-99.1 EX-99.1
• 07.16.2025 - 8-K Current report
• 06.20.2025 - 8-K Current report
• 06.17.2025 - 8-K Current report
• 06.02.2025 - 8-K/A Current report
• 05.13.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 05.13.2025 - 8-K Current report
• 05.13.2025 - EX-99.1 EX-99.1
• 05.01.2025 - 8-K Current report
• 05.01.2025 - EX-99.1 EX-99.1